OPCH - NASDAQ
Option Care Health, Inc.
$20.53
+1.2%Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
At a Glance
Live SnapshotOption Care Health, Inc. Management Team
Mr. John C. Rademacher
Chief Executive Officer, President & Director
Compensation
$2,222,800
Mr. Christopher L. Grashoff
Chief Growth Officer
Compensation
$734,200
Mr. Michael Bavaro
Chief Human Resources & Chief Diversity Officer
Compensation
$981,869
Mr. Brett Michalak
Chief Information Officer
Mr. Luke Whitworth
Chief Operating Officer
Compensation
$1,168,985
Mr. Michael H. Shapiro
Executive Vice President & Chief Financial Officer
Compensation
$1,115,288
Ms. Meenal Anil Sethna CPA
Executive Vice President & Chief Financial Officer
Mr. Collin G. Smyser
General Counsel & Corporate Secretary
Compensation
$859,795
Ms. Stacey Mahone
Senior Vice President & Chief Compliance Officer
Ms. Julie Koenig
Senior Vice President of Operations
Mr. Jorge Ramirez
Senior Vice President of Strategy and Corporate Development
Ms. Nicole Maggio
Senior Vice President, Controller & Principal Accounting Officer
Option Care Health, Inc. Insider Positioning
During the last 12 months, insiders have purchased $4.54M and sold $1.17M worth of OPCH shares, resulting in $3.37M of net buying activity.
3 Months
89.5K
1.88M
0
0.00
+1.9M
+$1.88M
3-6 Months
0
0.00
36.3K
1.17M
-1.2M
-$1.17M
6-9 Months
41.4K
1.09M
0
0.00
+1.1M
+$1.09M
9-12 Months
57.8K
1.58M
0
0.00
+1.6M
+$1.58M
Top Buyers
Kraemer Harry M Jansen Jr
Director
$2.75M
Sullivan Timothy P
Director
$1.05M
Sethna Meenal
Officer: Chief Financial Officer
$327K
Rademacher John Charles
Director, Officer: Chief Executive Officer
$265K
Wright Norman L.
Director
$100K
Top Sellers
Pate R Carter
Director
$971K
Bavaro Michael
Officer: Chief Human Resources Officer
$198K
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $3.37M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Recent Trend (3 Months)
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
Insider Participation
5 insider buyers vs. 2 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
SEC Filings
OPCH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 08, 2026 | May 20, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 02, 2025 | May 14, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 03, 2024 | May 15, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 07, 2023 | April 07, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 06, 2022 | May 18, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 07, 2021 | May 19, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 10, 2020 | May 22, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 30, 2019 | June 11, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 04, 2018 | May 03, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 05, 2017 | May 02, 2017 | 2017 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.